Contact
searchSearch
HMP Global
Login

videos

Natalie Callander, MD
Videos
The Future of Cellular Therapies in Earlier Lines of Multiple Myeloma Treatment
03/06/2026
Natalie Callander, MD
Natalie Callander, MD, shares insights into progress of utilizing cellular therapies in earlier lines of therapy in the multiple myeloma treatment landscape.
Natalie Callander, MD, shares insights into progress of utilizing cellular therapies in earlier lines of therapy in the multiple myeloma treatment landscape.
Natalie Callander, MD, shares...
03/06/2026
Oncology
Matthew Davids, MD
Videos
Genetic Risk Factors May Help Predict Richter Transformation in Chronic Lymphocytic Leukemia
01/05/2026
Matthew S. Davids, MD, MMSc
Matthew Davids, MD, highlights advances in identifying and managing Richter transformation among patients with chronic lymphocytic leukemia.
Matthew Davids, MD, highlights advances in identifying and managing Richter transformation among patients with chronic lymphocytic leukemia.
Matthew Davids, MD, highlights...
01/05/2026
Oncology
Joseph Mikhael, MD
Videos
Optimizing Sequencing of CAR T-Cell and Bispecific Therapies to Improve Multiple Myeloma Outcomes
01/05/2026
Joseph Mikhael, MD, MEd, FRCPC
Joseph Mikhael, MD, explains the importance of strategic sequencing and safety optimization for multiple myeloma immunotherapies.
Joseph Mikhael, MD, explains the importance of strategic sequencing and safety optimization for multiple myeloma immunotherapies.
Joseph Mikhael, MD, explains the...
01/05/2026
Oncology
Adriana Rossi, MD
Videos
Emerging Patterns of Delayed CAR T-Cell Therapy Toxicities
01/02/2026
Adriana Rossi, MD
Adriana Rossi, MD, discussed the importance of monitoring for delayed CAR T-cell therapy toxicities such as neurotoxicity, colitis, and prolonged cytopenias as treatment use for patients expands, at the 2025 Lymphoma, Leukemia & Myeloma...
Adriana Rossi, MD, discussed the importance of monitoring for delayed CAR T-cell therapy toxicities such as neurotoxicity, colitis, and prolonged cytopenias as treatment use for patients expands, at the 2025 Lymphoma, Leukemia & Myeloma...
Adriana Rossi, MD, discussed the...
01/02/2026
Oncology
Joshua Richter, MD
Conference Coverage
Addressing Disparities in CAR-T Access in Treating Multiple Myeloma
12/01/2025
Joshua Richter, MD
Joshua Richter, MD, shares details on the long-term efficacy of CAR T-cell therapy for patients with multiple myeloma and highlights the need for expanded, equitable access for all patients at the 2025 Lymphoma, Leukemia & Myeloma Congress.
Joshua Richter, MD, shares details on the long-term efficacy of CAR T-cell therapy for patients with multiple myeloma and highlights the need for expanded, equitable access for all patients at the 2025 Lymphoma, Leukemia & Myeloma Congress.
Joshua Richter, MD, shares...
12/01/2025
Oncology
Mark Bustoros, MD
Conference Coverage
Utilizing Genomic Profiling to Refine Risk Stratification for Smoldering and Newly Diagnosed Multiple Myeloma
12/01/2025
Mark Bustoros, MD
Mark Bustoros, MD, discusses how genomic profiling improves risk assessment, guides treatment intensity, and reveals mechanisms of resistance in multiple myeloma across disease stages at the 2025 Lymphoma, Leukemia & Myeloma Congress.
Mark Bustoros, MD, discusses how genomic profiling improves risk assessment, guides treatment intensity, and reveals mechanisms of resistance in multiple myeloma across disease stages at the 2025 Lymphoma, Leukemia & Myeloma Congress.
Mark Bustoros, MD, discusses how...
12/01/2025
Oncology
Jia Ruan, MD, PhD
Videos
Emerging Targeted Therapies for Peripheral T-Cell Lymphoma
11/06/2025
Jia Ruan, MD, PhD
Jia Ruan, MD, shares insights into novel targeted therapies for patients with peripheral T-cell lymphoma at the 2025 Lymphoma, Leukemia, & Myeloma Congress.
Jia Ruan, MD, shares insights into novel targeted therapies for patients with peripheral T-cell lymphoma at the 2025 Lymphoma, Leukemia, & Myeloma Congress.
Jia Ruan, MD, shares insights...
11/06/2025
Oncology
Leo Gordon, MD
Videos
Latest Updates in Therapeutic Approaches for Patients With Extranodal Marginal Zone Lymphoma
10/17/2025
Leo Gordon, MD, FACP
At the 2025 Lymphoma, Leukemia, & Myeloma Congress, Leo Gordon, MD, FACP, discusses the latest updates in therapeutic approaches to treating patients with extranodal marginal zone lymphoma.
At the 2025 Lymphoma, Leukemia, & Myeloma Congress, Leo Gordon, MD, FACP, discusses the latest updates in therapeutic approaches to treating patients with extranodal marginal zone lymphoma.
At the 2025 Lymphoma, Leukemia,...
10/17/2025
Oncology
Catherine Diefenbach, MD
Videos
Optimizing Management of Diffuse Large B-Cell Lymphoma for Patients in First Relapse
10/17/2025
Catherine Diefenbach, MD
Catherine Diefenbach, MD, shares the latest insights into the treatment and management of recurrent diffuse large B-cell lymphoma at the 2025 Lymphoma, Leukemia & Myeloma Congress.
Catherine Diefenbach, MD, shares the latest insights into the treatment and management of recurrent diffuse large B-cell lymphoma at the 2025 Lymphoma, Leukemia & Myeloma Congress.
Catherine Diefenbach, MD, shares...
10/17/2025
Oncology
Sarah Rutherford, MD
Videos
Approaches and Strategies for Treating Elderly Patients With Hodgkin Lymphoma
10/17/2025
Sarah C. Rutherford, MD
At the 2025 Lymphoma, Leukemia, & Myeloma Congress, Sarah Rutherford, MD, shares case presentations of elderly patients with Hodgkin lymphoma and the strategies she utilizes to treat these patients.
At the 2025 Lymphoma, Leukemia, & Myeloma Congress, Sarah Rutherford, MD, shares case presentations of elderly patients with Hodgkin lymphoma and the strategies she utilizes to treat these patients.
At the 2025 Lymphoma, Leukemia,...
10/17/2025
Oncology

About

For nearly 2 decades, the Lymphoma, Leukemia & Myeloma Congress (formerly the Lymphoma & Myeloma Congress) has been recognized around the world as the most respected forum for industry-leading hematologic research.

It’s where interdisciplinary specialists convene to explore the controversial and the complex, the emerging and the exciting, and discuss, debate, and discover along the way.

This program features 4 days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use